Transgene (France) Price on December 27, 2024
TNG Stock | EUR 0.70 0.01 1.41% |
If you're considering investing in Transgene Stock, it is important to understand the factors that can impact its price. As of today, the current price of Transgene stands at 0.70, as last reported on the 28th of December, with the highest price reaching 0.71 and the lowest price hitting 0.70 during the day. Transgene SA owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.21, which indicates the firm had a -0.21% return per unit of risk over the last 3 months. Transgene SA exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Transgene's Variance of 10.29, coefficient of variation of (620.59), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide.
Transgene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Transgene |
Sharpe Ratio = -0.2121
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TNG |
Estimated Market Risk
3.19 actual daily | 28 72% of assets are more volatile |
Expected Return
-0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Transgene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transgene by adding Transgene to a well-diversified portfolio.
Transgene Valuation on December 27, 2024
It is possible to determine the worth of Transgene on a given historical date. On December 27, 2024 Transgene was worth 0.71 at the beginning of the trading date compared to the closed value of 0.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Transgene stock. Still, in general, we apply an absolute valuation method to find Transgene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Transgene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Transgene's related companies.
Open | High | Low | Close | Volume | |
0.70 | 0.71 | 0.70 | 0.70 | 10,900 | |
12/27/2024 | 0.71 | 0.71 | 0.70 | 0.70 | 21,946 |
Backtest Transgene | | | Transgene History | | | Transgene Valuation | Previous |
Transgene Trading Date Momentum on December 27, 2024
On December 27 2024 Transgene SA was traded for 0.70 at the closing time. The maximum traded price for the trading interval was 0.71 and the lowest daily price was 0.70 . The daily volume was recorded at 21.9 K. The volume of trading on 27th of December 2024 did not result in any price rise and fall. The trading price change to the closing price today is 1.43% . |
Transgene SA Fundamentals Correlations and Trends
By evaluating Transgene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Transgene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Transgene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Transgene Stock history
Transgene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transgene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transgene SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transgene stock prices may prove useful in developing a viable investing in Transgene
Transgene SA, a biotechnology company, designs, develops, and produces therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company was founded in 1979 and is headquartered in Illkirch-Graffenstaden, France. TRANSGENE operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 132 people.
Transgene Stock Technical Analysis
Transgene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Transgene Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Transgene SA cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Transgene December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Transgene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Transgene shares will generate the highest return on investment. By undertsting and applying Transgene stock market strength indicators, traders can identify Transgene SA entry and exit signals to maximize returns
Transgene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Transgene's price direction in advance. Along with the technical and fundamental analysis of Transgene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Transgene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (0.53) | |||
Total Risk Alpha | (0.62) | |||
Treynor Ratio | (3.28) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Transgene Stock analysis
When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |